{"id":"https://openalex.org/W2147467548","doi":"https://doi.org/10.1185/030079903125001884","title":"Review of the safety, tolerability, and drug interactions of the new antifungal agents caspofungin and voriconazole","display_name":"Review of the safety, tolerability, and drug interactions of the new antifungal agents caspofungin and voriconazole","alternate_titles":[],"publication_year":2003,"publication_date":"2003-01-01","ids":{"openalex":"https://openalex.org/W2147467548","doi":"https://doi.org/10.1185/030079903125001884","mag":"2147467548","pmid":"https://pubmed.ncbi.nlm.nih.gov/12841918"},"language":"en","primary_location":{"id":"doi:10.1185/030079903125001884","doi":"https://doi.org/10.1185/030079903125001884","is_oa":false,"landing_page_url":"https://doi.org/10.1185/030079903125001884","pdf_url":null,"source":{"id":"https://openalex.org/S206643269","display_name":"Current Medical Research and Opinion","issn_l":"0300-7995","issn":["0300-7995","1473-4877"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Medical Research and Opinion","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2147467548"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5002521314","display_name":"Andrew J. Ullmann","orcid":"https://orcid.org/0000-0002-8191-6517","observed_orcids":["https://orcid.org/0000-0002-8191-6517"]},"institutions":[{"id":"https://openalex.org/I197323543","display_name":"Johannes Gutenberg University Mainz","ror":"https://ror.org/023b0x485","country_code":"DE","type":"education","lineage":["https://openalex.org/I197323543"]},{"id":"https://openalex.org/I4210094062","display_name":"University Medical Center of the Johannes Gutenberg University Mainz","ror":"https://ror.org/00q1fsf04","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210094062"]}],"countries":["DE"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Andrew J. Ullmann","raw_affiliation_strings":["Klinikum Johannes Gutenberg-Universit\u00e4t, Mainz, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Klinikum Johannes Gutenberg-Universit\u00e4t, Mainz, Germany","institution_ids":["https://openalex.org/I197323543","https://openalex.org/I4210094062"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5002521314"],"corresponding_institution_ids":["https://openalex.org/I197323543","https://openalex.org/I4210094062"],"apc_list":null,"apc_paid":null,"fwci":6.0306,"has_fulltext":false,"cited_by_count":85,"citation_normalized_percentile":{"value":0.9703733,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"19","issue":"4","first_page":"263","last_page":"271"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11037","display_name":"Fungal Infections and Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/caspofungin","display_name":"caspofungin","score":0.996999979019165},{"id":"https://openalex.org/keywords/voriconazole","display_name":"voriconazole","score":1.0},{"id":"https://openalex.org/keywords/antifungal-agents","display_name":"antifungal agents","score":0.9100000262260437},{"id":"https://openalex.org/keywords/invasive-fungal-infections","display_name":"invasive fungal infections","score":0.8149999976158142},{"id":"https://openalex.org/keywords/immunocompromised-patients","display_name":"immunocompromised patients","score":0.8679999709129333},{"id":"https://openalex.org/keywords/drug-safety-and-tolerability","display_name":"drug safety and tolerability","score":0.777999997138977},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.984000027179718},{"id":"https://openalex.org/keywords/cyclosporine","display_name":"cyclosporine","score":0.8980000019073486},{"id":"https://openalex.org/keywords/hepatotoxicity","display_name":"hepatotoxicity","score":0.5759999752044678},{"id":"https://openalex.org/keywords/triazole-antifungals","display_name":"triazole antifungals","score":0.7160000205039978},{"id":"https://openalex.org/keywords/echinocandins","display_name":"echinocandins","score":0.8830000162124634},{"id":"https://openalex.org/keywords/aspergillus","display_name":"Aspergillus","score":0.7480000257492065},{"id":"https://openalex.org/keywords/candida","display_name":"Candida","score":0.9980000257492065},{"id":"https://openalex.org/keywords/cytochrome-p450-metabolism","display_name":"cytochrome P450 metabolism","score":0.8880000114440918},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.6449999809265137}],"concepts":[{"id":"https://openalex.org/C2780690907","wikidata":"https://www.wikidata.org/wiki/Q412236","display_name":"Voriconazole","level":3,"score":0.969192385673523},{"id":"https://openalex.org/C2780402444","wikidata":"https://www.wikidata.org/wiki/Q420875","display_name":"Caspofungin","level":4,"score":0.964332640171051},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.8517314791679382},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7801885604858398},{"id":"https://openalex.org/C2779320740","wikidata":"https://www.wikidata.org/wiki/Q3718510","display_name":"Echinocandin","level":4,"score":0.5501379370689392},{"id":"https://openalex.org/C2776391196","wikidata":"https://www.wikidata.org/wiki/Q259626","display_name":"Aspergillosis","level":2,"score":0.5309925079345703},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5188992619514465},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4560747742652893},{"id":"https://openalex.org/C2780651595","wikidata":"https://www.wikidata.org/wiki/Q411478","display_name":"Fluconazole","level":3,"score":0.4088747799396515},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3871901333332062},{"id":"https://openalex.org/C2779548794","wikidata":"https://www.wikidata.org/wiki/Q578726","display_name":"Antifungal","level":2,"score":0.24985134601593018},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.12777799367904663},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.09813588857650757}],"mesh":[{"descriptor_ui":"D000077336","descriptor_name":"Caspofungin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001228","descriptor_name":"Aspergillosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D002177","descriptor_name":"Candidiasis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D010456","descriptor_name":"Peptides, Cyclic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054714","descriptor_name":"Echinocandins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055666","descriptor_name":"Lipopeptides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065819","descriptor_name":"Voriconazole","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1185/030079903125001884","doi":"https://doi.org/10.1185/030079903125001884","is_oa":false,"landing_page_url":"https://doi.org/10.1185/030079903125001884","pdf_url":null,"source":{"id":"https://openalex.org/S206643269","display_name":"Current Medical Research and Opinion","issn_l":"0300-7995","issn":["0300-7995","1473-4877"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Medical Research and Opinion","raw_type":"journal-article"},{"id":"pmid:12841918","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12841918","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current medical research and opinion","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":23,"referenced_works":["https://openalex.org/W1964720826","https://openalex.org/W1967302854","https://openalex.org/W1986100989","https://openalex.org/W1997264973","https://openalex.org/W2003661565","https://openalex.org/W2016290575","https://openalex.org/W2024310762","https://openalex.org/W2027962943","https://openalex.org/W2029714817","https://openalex.org/W2040017988","https://openalex.org/W2041457471","https://openalex.org/W2054676531","https://openalex.org/W2082695689","https://openalex.org/W2083330927","https://openalex.org/W2106715375","https://openalex.org/W2108751484","https://openalex.org/W2129444140","https://openalex.org/W2142281465","https://openalex.org/W2144030592","https://openalex.org/W2156228013","https://openalex.org/W2313994904","https://openalex.org/W2442059612","https://openalex.org/W4367592963"],"related_works":["https://openalex.org/W2467543381","https://openalex.org/W2606254112","https://openalex.org/W1970783179","https://openalex.org/W1990005834","https://openalex.org/W2121959809","https://openalex.org/W2095005202","https://openalex.org/W157973430","https://openalex.org/W4236380909","https://openalex.org/W2041457471"],"abstract_inverted_index":{"Managing":[0],"invasive":[1,85],"fungal":[2,56,71],"infections":[3],"often":[4],"presents":[5],"a":[6,35,67,99,160],"challenge":[7],"for":[8,124],"clinicians":[9],"in":[10,54,63,70,105,145],"the":[11,30,42,50,55,64,119,122,132,164,176,180],"treatment":[12],"of":[13,52,95,102,112,156,163,185],"immunocompromised":[14],"patients.":[15,125],"Two":[16],"very":[17,150],"different":[18],"systemic":[19],"antifungal":[20],"agents,":[21],"voriconazole":[22,157],"and":[23,87,92,140,182,193],"caspofungin,":[24],"have":[25],"recently":[26],"been":[27,115],"introduced":[28],"into":[29],"market":[31],"place.":[32],"Voriconazole":[33,46,126],"is":[34,41],"new":[36],"triazole":[37],"antifungal,":[38],"while":[39],"caspofungin":[40,96],"first":[43],"echinocandin":[44],"antifungal.":[45],"acts":[47],"by":[48],"inhibiting":[49],"synthesis":[51,62],"ergosterol":[53],"cell":[57,65],"membrane.":[58],"Caspofungin":[59],"inhibits":[60],"beta-1,3-D-glucan":[61],"wall,":[66],"target":[68],"present":[69],"cells,":[72],"but":[73],"absent":[74],"from":[75],"mammalian":[76],"cells.":[77],"Both":[78],"agents":[79],"are":[80],"broad-spectrum,":[81],"with":[82,98],"efficacy":[83],"against":[84],"Aspergillus":[86],"Candida":[88],"infections.":[89],"The":[90,152],"safety":[91,181],"tolerability":[93,183],"profile":[94,155],"presented":[97],"low":[100],"incidence":[101],"adverse":[103],"events":[104],"clinical":[106],"trials.":[107],"Pending":[108],"further":[109],"data,":[110],"coadministration":[111],"cyclosporine":[113],"has":[114,127],"recommended":[116],"only":[117],"if":[118],"benefit":[120],"outweighs":[121],"risk":[123],"three":[128],"important":[129],"side-effects":[130],"that":[131],"clinician":[133],"must":[134],"consider:":[135],"liver":[136],"abnormalities,":[137],"skin":[138],"abnormalities":[139,144],"visual":[141],"disturbances.":[142],"Liver":[143],"particular":[146],"should":[147],"be":[148],"monitored":[149],"carefully.":[151],"drug":[153,191],"interaction":[154],"also":[158],"warrants":[159],"careful":[161],"evaluation":[162],"concomitant":[165],"medication,":[166],"mainly":[167],"due":[168],"to":[169],"cytochrome":[170],"P450":[171],"metabolism.":[172],"This":[173],"article":[174],"reviews":[175],"available":[177],"data":[178],"concerning":[179],"profiles":[184],"each":[186],"drug,":[187],"as":[188,190],"well":[189],"interactions":[192],"contraindications.":[194]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2147467548","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
